CNS5:Volunteer Assignments and Opportunities: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vol..."
 
m due date
 
(52 intermediate revisions by 5 users not shown)
Line 2: Line 2:


For assignments, please see the "Author" column below (highlighted blue).
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
If empty (no name is present), please volunteer to create content for that disease!


To volunteer, please [Contact us] with your page of interest.
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
 
__TOC__
==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
{| class="wikitable" style="margin:auto"
{| class="wikitable"
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
|-
|-
!'''Disease'''!!'''Page Type'''!!'''Author'''
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Target Completion Date'''
Line 17: Line 18:
!'''Notes'''
!'''Notes'''
|-
|-
|Astrocystoma, IDH-Mutant
|
====CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)====
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|
----
|-
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
|Disease
|Disease
|Meenakshi Mehrotra
|Meenakshi Mehrotra
|6/25/2023
|6/25/2023
|
|
|PENDING
|COMPLETE
|
|
|Laveniya Satgunaseelan (LS)
|Laveniya Satgunaseelan (LS)
Line 28: Line 50:
|2021 template added
|2021 template added
|-
|-
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
|Disease
|Riley Lochner (trainee);
Shashi Shetty (mentor)
|6/7/2022
|6/7/2022
|
|
Line 37: Line 62:
|2021 template added
|2021 template added
|-
|-
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
|
|Disease
|
|Jieying Wu
|11/18/2025
|01/15/2026
|PENDING
|PENDING
|
|
|LS
|LS
|
|
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
|-
|-
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
|Disease
|Scott Smith
|6/27/2023
|6/27/2023
|
|
|PENDING
|COMPLETE
|
|
|LS
|LS
Line 55: Line 84:
|2021 template added (page created 6/27/23)
|2021 template added (page created 6/27/23)
|-
|-
|Angiocentric Glioma||Disease||
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
|Disease
|
|
|
|
|
Line 64: Line 95:
|
|
|-
|-
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
|Disease
|
|
|
|
|
Line 73: Line 106:
|
|
|-
|-
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
|
|Disease
|
|Scott Smith
|
|5/3/2024
|
|
|PENDING - email reminder 9/4/2025
|
|
|LS
|
|
|
|
|-
|-
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
|Disease
|Laveniya Satgunaseelan
|
|
|
|
|PENDING
|COMPLETE
|
|
|LS
|LS
Line 91: Line 128:
|2021 template added
|2021 template added
|-
|-
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
|Disease
|Xiaolin (Lynn) Hu
|2/21/2022
|2/21/2022
|
|
Line 100: Line 139:
|2021 template added
|2021 template added
|-
|-
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
|Disease
|Madina Sukhanova
|10/28/2022
|10/28/2022
|
|
Line 109: Line 161:
|2021 template added
|2021 template added
|-
|-
|Infant-Type Hemispheric Glioma||Disease||
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
|Disease
|
|
|
|
|
|
Line 116: Line 171:
|
|
|
|
|2021 template added
|-
|-
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
|9/13/2022<br />
|Disease
|Layla Zhu
|<br />3/2/2026
|
|
|PENDING
|PENDING
Line 127: Line 183:
|2021 template added
|2021 template added
|-
|-
|High-Grade Astrocytoma with Piloid Features||Disease||
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
|
|Disease
|
|Wahab Khan
|2/8/2026
|
|
|PENDING
|
|
|
|
Line 136: Line 194:
|
|
|-
|-
|Pleomorphic Xanthoastrocytoma||Disease||
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
|
|Disease
|
|Wahab Khan
|
|15/04/2025
|
|
|COMPLETE
|2/8/2026 (Feb 8)
|LS
|LS
|
|
|2021 template added
|2021 template added
|-
|-
|Subependymal Giant Cell Astrocytoma||Disease||
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
|Disease
|
|
|
|
|
Line 154: Line 216:
|
|
|-
|-
|Chordoid Glioma||Disease||
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
|Disease
|
|
|
|
|
Line 163: Line 227:
|
|
|-
|-
|Astroblastoma, MN1-Altered||Disease||
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
|
|Disease
|
|Milana.Djonovic (trainee), Laveniya/Madina
|
|4/26/2026
|
|6/15/2026
|PENDING
|
|
|LS
|
|
|
|
|-
|-
|Ganglioglioma||Disease||Leila Moayed-Aloei
|[[CNS5:Ganglioglioma|Ganglioglioma]]
|Disease
|Leila Moayed-Aloei
|6/30/2022
|6/30/2022
|
|
Line 181: Line 249:
|2021 template added
|2021 template added
|-
|-
|Gangliocytoma||Disease||
|[[CNS5:Gangliocytoma|Gangliocytoma]]
|Disease
|
|
|
|
|
Line 190: Line 260:
|
|
|-
|-
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
|Disease
|
|
|
|
|
Line 199: Line 282:
|
|
|-
|-
|Dysembryoplastic Neuroepithelial Tumour||Disease||
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
|Disease
|
|
|
|
|
Line 208: Line 293:
|
|
|-
|-
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
|Disease
|
|
|
|
|
Line 217: Line 304:
|
|
|-
|-
|Papillary Glioneuronal Tumour||Disease||
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 226: Line 315:
|
|
|-
|-
|Rosette-Forming Glioneuronal Tumour||Disease||
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 235: Line 326:
|
|
|-
|-
|Myxoid Glioneuronal Tumour||Disease||
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
|Disease
|
|
|
|
|
Line 244: Line 337:
|
|
|-
|-
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
|Disease
|Laveniya Satgunaseelan
|9/11/2024
|
|COMPLETE
|8/7/2025
|LS
|LS
|Used for testing 9/2024 somatic template
|-
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
|Disease
|
|
|
|
|
Line 253: Line 359:
|
|
|-
|-
|Multinodular and Vacuolating Neuronal Tumour||Disease||
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
|Disease
|
|
|
|
|
Line 262: Line 370:
|
|
|-
|-
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
|Disease
|
|
|
|
|
Line 271: Line 381:
|
|
|-
|-
|Central Neurocytoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
|Disease
|
|
|
|
|
Line 280: Line 403:
|
|
|-
|-
|Extraventricular Neurocytoma||Disease||
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
|Disease
|
|
|
|
|
Line 289: Line 414:
|
|
|-
|-
|Cerebellar Liponeurocytoma||Disease||
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
|Disease
|Laveniya Satgunaseelan
|2/4/2026
|30/6/2026
|PENDING
|
|
|
|
|
|
|
|-
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
|Disease
|Laveniya Satgunaseelan
|2/4/2026
|30/6/2026
|PENDING
|
|
|
|
Line 298: Line 436:
|
|
|-
|-
|Supratentorial Ependymoma||Disease||
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
|Disease
|Laveniya Satgunaseelan
|2/4/2026
|30/6/2026
|PENDING
|
|
|
|
|
|
|
|
|-
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
|Disease
|
|
|
|
|
|
|-
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
|
|
|
|
Line 313: Line 457:
|
|
|
|
|-
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
|Disease
|
|
|
|
|-
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
|
|
|
|
Line 323: Line 468:
|
|
|
|
|-
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
|Disease
|
|
|-
|Posterior Fossa Ependymoma||Disease||
|
|
|
|
Line 334: Line 480:
|
|
|-
|-
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
|Disease
|
|
|
|
|
Line 343: Line 491:
|
|
|-
|-
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
|Disease
|
|
|
|
Line 351: Line 500:
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Spinal Ependymoma||Disease||
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
|Disease
|
|
|
|
|
Line 361: Line 524:
|
|
|-
|-
|Spinal Ependymoma, MYCN-Amplified||Disease||
|[[CNS5:Subependymoma|Subependymoma]]
|Disease
|
|
|
|
|
Line 370: Line 535:
|
|
|-
|-
|Myxopapillary Ependymoma||Disease||
|
|
====CHAPTER 3 (CHOROID PLEXUS TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
----
|
----
|
----
|-
|-
|Subependymoma||Disease||
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
|Disease
|
|
|
|
|
Line 388: Line 567:
|
|
|-
|-
|Choroid Plexus Papilloma||Disease||
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
|Disease
|
|
|
|
|
Line 397: Line 578:
|
|
|-
|-
|Atypical Choroid Plexus Papilloma||Disease||
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
|Disease
|
|
|
|
|
Line 406: Line 589:
|
|
|-
|-
|Choroid Plexus Carcinoma||Disease||
|
|
====CHAPTER 4 (EMBRYONAL TUMOURS)====
|
----
|
----
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
|Disease
|Lisa Lansdon, PhD (LGG trainee just finished);
Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
|9/20/21
|9/20/21
|
|
Line 424: Line 622:
|2021 template added
|2021 template added
|-
|-
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
|Disease
|
|
|
|
|
Line 433: Line 633:
|
|
|-
|-
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
|Disease
|Hannah Wollenzien
|1/11/2026
|
|
|Pending
|
|
|MS
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
|Disease
|
|
|
|
|
|
|-
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
|
|
|
|
Line 448: Line 665:
|
|
|
|
|-
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
|Disease
|
|
|
|
|-
|Medulloblastoma, Histologically Defined||Disease||
|
|
|
|
Line 458: Line 676:
|
|
|
|
|-
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
|Disease
|
|
|-
|Atypical Teratoid/Rhabdoid Tumour||Disease||
|
|
|
|
Line 469: Line 688:
|
|
|-
|-
|Cribriform Neuroepithelial Tumour||Disease||
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
|Disease
|
|
|
|
|
Line 478: Line 699:
|
|
|-
|-
|Embryonal Tumour with Multilayered Rosettes||Disease||
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
|Disease
|
|
|
|
|
Line 487: Line 710:
|
|
|-
|-
|CNS Neuroblastoma, FOXR2-Activated||Disease||
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
|Disease
|
|
|
|
|
Line 496: Line 721:
|
|
|-
|-
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
|Disease
|
|
|
|
|
Line 505: Line 732:
|
|
|-
|-
|CNS Embryonal Tumour NEC/NOS||Disease||
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
|Disease
|
|
|
|
|
Line 514: Line 743:
|
|
|-
|-
|Pineocytoma||Disease||
|
|
====CHAPTER 5 (PINEAL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
|
|
----
|
|
----
|
----
|-
|[[CNS5:Pineocytoma|Pineocytoma]]
|Disease
|
|
|
|
Line 531: Line 771:
|
|
|
|
|-
|Pineoblastoma||Disease||
|
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
|Disease
|
|
|
|
|
|
|
|
|-
|Papillary Tumour of the Pineal Region||Disease||
|
|
|
|
|
|
|
|
|-
|[[CNS5:Pineoblastoma|Pineoblastoma]]
|Disease
|Fang Fang (trainee)+Katie Schieffer (mentor)
|11/19/2025
|6/15/2026
|Pending
|
|
|LS
|
|
|
|
|-
|-
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
|Disease
|
|
|
|
|
Line 559: Line 819:
|
|
|-
|-
|Schwannoma||Disease||
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
|Disease
|
|
|
|
|
Line 568: Line 830:
|
|
|-
|-
|Neurofibroma||Disease||
|
|
====CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Perineurioma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Schwannoma|Schwannoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Neurofibroma|Neurofibroma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Perineurioma|Perineurioma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Hybrid Nerve Sheath Tumours||Disease||
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
|Disease
|
|
|
|
Line 594: Line 935:
|
|
|
|
|-
|Malignant Melanotic Nerve Sheath Tumour||Disease||
|
|
|
|
|
|
|-
|
|
====CHAPTER 7 (MENINGIOMA)====
|
|
----
|
|
----
|
|
|-
----
|Malignant Peripheral Nerve Sheath Tumour||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Meningioma|Meningioma]]
|Disease
|
|
|-
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
|
|
|
|
Line 622: Line 971:
|
|
|-
|-
|Meningioma||Disease||
|
|
====CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Solitary Fibrous Tumour||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
|Disease
|
|
|
|
|
|
|-
|Haemangiomas and Vascular Malformations||Disease||
|
|
|
|
Line 646: Line 1,013:
|
|
|
|
|-
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
|Disease
|
|
|
|
|-
|Haemangioblastoma||Disease||
|
|
|
|
Line 656: Line 1,024:
|
|
|
|
|-
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
|Disease
|
|
|-
|Rhabdomyosarcoma||Disease||
|
|
|
|
Line 667: Line 1,036:
|
|
|-
|-
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
|Disease
|
|
|
|
|
Line 676: Line 1,047:
|
|
|-
|-
|CIC-Rearranged Sarcoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
|Disease
|
|
|
|
Line 684: Line 1,077:
|
|
|
|
|-
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
|
|
|
|
|-
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
|Disease
|[[STBT5:Volunteer Assignments and Opportunities|See STBT5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
|Disease
|
|
|
|
|
|
|-
|Ewing Sarcoma||Disease||
|
|
|
|
Line 700: Line 1,112:
|
|
|
|
|-
|[[CNS5:Chordoma|Chordoma]]
|Disease
|
|
|
|-
|Mesenchymal Chondrosarcoma||Disease||
|
|
|
|
Line 712: Line 1,124:
|
|
|-
|-
|Chondrosarcoma||Disease||
|
|
====CHAPTER 9 (MELANOCYTIC TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Chordoma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
|Disease
|
|
|
|
|
|
|-
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
|
|
|
|
Line 737: Line 1,155:
|
|
|
|
|-
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
|Disease
|
|
|-
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
|
|
|
|
Line 748: Line 1,167:
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
====CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Immunodeficiency-Associated CNS Lymphomas||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|Lymphomatoid Granulomatosis||Disease||
|
|
|
|
|
|
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
|Disease
|
|
|
|
|
|
|-
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
|
Line 781: Line 1,220:
|
|
|
|
|-
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|MALT Lymphoma of the Dura||Disease||
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
|
|Disease
|
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
|Disease
|
|
|-
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
|
|
|
|
Line 802: Line 1,265:
|
|
|-
|-
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
|Disease
|Jennie Thurston
|7/2/2023
|7/2/2023
|
|
Line 809: Line 1,274:
|MS
|MS
|
|
|2021 template added
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
|-
|-
|T-cell and NK/T-cell Lymphomas||Disease||
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
|Disease
|
|
|
|
|
Line 820: Line 1,287:
|
|
|-
|-
|Erdheim-Chester Disease||Disease||
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
|
|Disease
|
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
|Disease
|[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Rosai-Dorfman Disease||Disease||
|
|
====CHAPTER 11 (GERM CELL TUMOURS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Juvenile Xanthogranuloma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
|Disease
|
|
|
|
|
|
|
|
|-
|Langerhans Cell Histiocytosis||Disease||
|
|
|
|
|
|
|
|
|-
|
|
====CHAPTER 12 (TUMOURS OF THE SELLAR REGION====
|
|
----
|
|
|-
----
|Histiocytic Sarcoma||Disease||
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|-
|-
|Germ Cell Tumours of the CNS||Disease||
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
|Disease
|
|
|
|
|
Line 874: Line 1,417:
|
|
|-
|-
|Adamantinomatous Craniopharyngioma||Disease||
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
|Disease
|
|
|
|
|
Line 883: Line 1,428:
|
|
|-
|-
|Papillary Craniopharyngioma||Disease||
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
|Disease
|
|
|
|
|
Line 892: Line 1,439:
|
|
|-
|-
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
|Disease
|
|
|
|
|
Line 901: Line 1,450:
|
|
|-
|-
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
|Disease
|
|
|
|
|
Line 910: Line 1,461:
|
|
|-
|-
|Pituitary Blastoma||Disease||
!'''Disease'''
!'''Page Type'''
!'''<span style="color:#0070C0">Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|
|
====CHAPTER 13 (METASTASES TO THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
|Disease
|
|
|
|
|
|
|
|-
|Metastases to the Meninges||Disease||
|
|
|
|
Line 934: Line 1,503:
|
|
|
|
|-
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
|Disease
|
|
|
|
|-
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
|
|
|
|
Line 944: Line 1,514:
|
|
|
|
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|-
|Neurofibromatosis Type 2||Disease||
|
|
====CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)====
|
|
----
|
|
----
|
|
----
|
|
----
|
|
----
|
|
|-
----
|Schwannomatosis||Disease||
|
|
----
|
|
----
|
|
----
|-
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Schwannomatosis|Schwannomatosis]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Von Hippel-Lindau Syndrome||Disease||
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|N/A
|
|
|-
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Tuberous Sclerosis||Disease||
!'''Disease'''
|
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|-
|-
|Li-Fraumeni Syndrome||Disease||
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|Cowden Syndrome||Disease||
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
|7/2/2023
|Disease
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|PENDING
|
|LS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|-
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
|8/22/2023
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|PENDING
|N/A
|N/A
|N/A
|N/A
|N/A
|N/A
|
|
|LS/MS
|
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|-
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
|[[CNS5:Carney_complex|Carney complex]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|Rhabdoid Tumour Predisposition Syndrome||Disease||
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|Carney Complex||Disease||
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|DICER1 Syndrome||Disease||Jennie Thurston
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
|7/2/2023
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|PENDING
|N/A
|
|N/A
|LS
|N/A
|N/A
|N/A
|N/A
|
|
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|-
|Familial Paraganglioma Syndromes||Disease||
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
|
|Disease
|
|
|
|
|
|
|
|-
|Melanoma-Astrocytoma Syndrome||Disease||
|
|
|
|
Line 1,072: Line 1,723:
|
|
|-
|-
|Familial Retinoblastoma||Disease||
!'''Disease'''
|
!'''Page Type'''
|
!'''<span style="color:#0070C0">Author'''
|
!'''Date Assigned to Author'''
|
!'''Target Completion Date'''
|
!'''Author Content (Pending or Complete)'''
|
!'''Date Completed by Author'''
|
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|BAP1 Tumour Predisposition Syndrome||Disease||
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|Fanconi Anaemia||Disease||
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|ELP1-Medulloblastoma Syndrome||Disease||
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
|
|Disease
|
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
|
|N/A
|
|N/A
|
|N/A
|
|N/A
|N/A
|N/A
|
|
|-
|-
|}<br />
|}

Latest revision as of 11:05, 28 April 2026

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
Astrocytoma, IDH-mutant Disease Meenakshi Mehrotra 6/25/2023 COMPLETE Laveniya Satgunaseelan (LS) 2021 template added
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease Riley Lochner (trainee);

Shashi Shetty (mentor)

6/7/2022 COMPLETE LS 2021 template added
Glioblastoma, IDH-wildtype Disease Jieying Wu 11/18/2025 01/15/2026 PENDING LS Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
Diffuse astrocytoma, MYB- or MYBL1-altered Disease Scott Smith 6/27/2023 COMPLETE LS 2021 template added (page created 6/27/23)
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease Scott Smith 5/3/2024 PENDING - email reminder 9/4/2025 LS
Diffuse midline glioma, H3 K27-altered Disease Laveniya Satgunaseelan COMPLETE LS 2021 template added
Diffuse hemispheric glioma, H3 G34-mutant Disease Xiaolin (Lynn) Hu 2/21/2022 COMPLETE LS 2021 template added
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease Madina Sukhanova 10/28/2022 COMPLETE LS 2021 template added
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease Layla Zhu
3/2/2026 		PENDING LS 2021 template added
High-grade astrocytoma with piloid features Disease Wahab Khan 2/8/2026 PENDING
Pleomorphic xanthoastrocytoma Disease Wahab Khan 15/04/2025 COMPLETE 2/8/2026 (Feb 8) LS 2021 template added
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease Milana.Djonovic (trainee), Laveniya/Madina 4/26/2026 6/15/2026 PENDING LS
Ganglioglioma Disease Leila Moayed-Aloei 6/30/2022 COMPLETE LS 2021 template added
Gangliocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease Laveniya Satgunaseelan 9/11/2024 COMPLETE 8/7/2025 LS LS Used for testing 9/2024 somatic template
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease Laveniya Satgunaseelan 2/4/2026 30/6/2026 PENDING
Supratentorial ependymoma, ZFTA fusion-positive Disease Laveniya Satgunaseelan 2/4/2026 30/6/2026 PENDING
Supratentorial ependymoma, YAP1 fusion-positive Disease Laveniya Satgunaseelan 2/4/2026 30/6/2026 PENDING
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Myxopapillary ependymoma Disease
Subependymoma Disease

CHAPTER 3 (CHOROID PLEXUS TUMOURS)
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease

CHAPTER 4 (EMBRYONAL TUMOURS)
Medulloblastoma, WNT-activated Disease Lisa Lansdon, PhD (LGG trainee just finished);

Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City

9/20/21 COMPLETE Holli Drendel (interim)/Laveniya Satgunaseelan (LS) 9/22/2022 2021 template added
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease Hannah Wollenzien 1/11/2026 Pending MS
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease

CHAPTER 5 (PINEAL TUMOURS)
Pineocytoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease Fang Fang (trainee)+Katie Schieffer (mentor) 11/19/2025 6/15/2026 Pending LS
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease

CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
Schwannoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Neurofibroma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Perineurioma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Hybrid nerve sheath tumours Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Malignant melanotic nerve sheath tumour Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Malignant peripheral nerve sheath tumour Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease

CHAPTER 7 (MENINGIOMA)
Meningioma Disease

CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
Solitary fibrous tumour Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CIC-rearranged sarcoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Mesenchymal chondrosarcoma Disease See STBT5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Chondrosarcoma Disease
Chordoma Disease

CHAPTER 9 (MELANOCYTIC TUMOURS)
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease

CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
Primary diffuse large B-cell lymphoma of the CNS Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Intravascular large B-cell lymphoma Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
MALT lymphoma of the dura Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease Jennie Thurston 7/2/2023 PENDING MS 2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)" and "ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)"?
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Rosai-Dorfman disease Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Juvenile xanthogranuloma Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Langerhans cell histiocytosis Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Histiocytic sarcoma Disease See HAEM5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A

CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours of the CNS Disease

CHAPTER 12 (TUMOURS OF THE SELLAR REGION
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes

CHAPTER 13 (METASTASES TO THE CNS)
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease

CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Schwannomatosis Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Tuberous sclerosis Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
Cowden syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Constitutional mismatch repair deficiency syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Familial adenomatous polyposis 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Naevoid basal cell carcinoma syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Rhabdoid tumour predisposition syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Carney complex Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Familial paraganglioma syndromes Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Melanoma-astrocytoma syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Familial retinoblastoma Disease
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
BAP1 tumour predisposition syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Fanconi anaemia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
ELP1-medulloblastoma syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A
Retrieved from "https://content.ccga.io/index.php?title=CNS5:Volunteer_Assignments_and_Opportunities&oldid=21175"